-
Arrb2, 6-ketoLCA, and Hepatic I/R Injury
2026-09-29
This study identifies hepatocyte Arrb2 as an upstream regulator of macrophage behavior during hepatic ischemia–reperfusion injury, linking parenchymal signaling to the metabolite 6-ketoLCA and M2 polarization. Its combination of clinical association, hepatocyte-focused mouse genetics, hypoxia–reoxygenation models, and metabolomics provides a useful framework for investigating immunometabolic control of liver injury.
-
Hexose Diphosphate for Reliable Cell Assays
2026-09-29
Learn how hexose diphosphate (SKU M1436) can improve the interpretability of cell viability, proliferation, cytotoxicity, and metabolic-flux experiments. This scenario-based guide emphasizes water compatibility, fresh-solution handling, appropriate controls, and the distinction between established product data and hypotheses from recent glycolytic-metabolite research.
-
Amikacin (BAY416651) in Resistance Research
2026-09-28
Use Amikacin (BAY416651) to add an aminoglycoside susceptibility readout to studies of carbapenem-resistant Enterobacter cloacae and other resistant bacteria. This workflow-focused guide explains how to prepare the compound, compare phenotypes with resistance genotypes, and troubleshoot results without confusing aminoglycoside activity with carbapenemase status.
-
Alfuzosin for BPH: Evidence and Clinical Pharmacology
2026-09-27
Mary Lee’s 2003 review synthesizes alfuzosin’s pharmacology, pharmacokinetics, clinical efficacy, and adverse effects in benign prostatic hyperplasia (BPH). Its central contribution is to frame alfuzosin as a functionally uroselective α1 adrenoceptor antagonist that can improve urinary symptoms and flow while helping researchers interpret the balance between lower urinary tract benefit and cardiovascular effects.
-
Minoxidil sulphate: Research Evidence and Handling
2026-09-26
Minoxidil sulphate is the active metabolite of minoxidil and a research compound used to investigate potassium-channel activation, hair follicle biology, and vascular responses. Product specifications describe its identity, purity, solubility, and storage, while a septic-rat study provides important context about potassium channels in renal vascular responses—not direct evidence for minoxidil sulphate efficacy.
-
Reactive Oxygen Species Assay Kit for FLASH-RT
2026-09-26
Connect live-cell ROS measurements with radiosensitization experiments using the DCFH-DA fluorescent probe and a practical control-led workflow. The guide translates findings from BRD4-targeted FLASH radiotherapy research into assay choices while distinguishing suggested starting conditions from validated kit specifications.
-
AURKA Overexpression in Human Retinoblastoma
2026-09-25
A 2024 study links elevated Aurora kinase A (AURKA) in human retinoblastoma to histopathologic high-risk features and supports a functional role for the kinase in tumor cells. By combining patient-tissue analysis with AURKA depletion and pharmacologic studies, the work provides a rationale for further target-validation research, not evidence of established clinical benefit.
-
Formononetin Protects Against Oxaliplatin Neurotoxicity
2026-09-25
A cell-based study found that formononetin reduced oxaliplatin-induced oxidative stress and neuronal apoptosis through Nrf2/HO-1-associated responses, while preserving oxaliplatin’s anticancer effects in two cancer cell lines. The results identify a promising preclinical strategy for separating neuroprotection from loss of chemotherapy activity, but do not establish clinical benefit or protection across all chemotherapy drugs.
-
Esculetin Limits CKLF1-Linked Inflammation After Stroke
2026-09-24
A mouse study reports that esculetin reduces post-stroke neutrophil infiltration and improves behavioral and imaging measures, with effects linked to the chemokine-like factor CKLF1 and its association with CCR5. The findings support CKLF1-mediated inflammation as a candidate mechanism for preclinical stroke-recovery research, but do not establish clinical benefit or an effective treatment in people.
-
Gamma-linolenic acid (GLA): Assay Design Guide
2026-09-24
A practical guide to using Gamma-linolenic acid (GLA), SKU C5518, in cell viability and inflammation studies. It interprets reported activity alongside solvent, storage, and control considerations so researchers can plan dose-response experiments without confusing GLA findings with evidence for other fatty acids.
-
ω-Agatoxin IVA TFA: Cav2.1 Workflow
2026-09-23
ω-Agatoxin IVA TFA enables selective interrogation of Cav2.1-mediated calcium entry, presynaptic release, and seizure-related circuitry without the broad activity expected from nonspecific calcium channel blockers. Its strongest use-case is a matched workflow that combines neuronal calcium current recording with synaptic transmission and epilepsy animal model validation.
-
Novobiocin Sodium: From Gyrase to Translation
2026-09-23
Novobiocin Sodium is more than a classic aminocoumarin antibiotic: it is a mechanistic probe for bacterial DNA replication, DNA damage biology, antibiotic resistance research, and emerging antiparasitic discovery. This thought-leadership guide explains how to position the compound across translational workflows while separating established evidence from promising but preliminary hypotheses.
-
Deferiprone: Reliable Iron-Dependent Cell Assays
2026-09-22
This scenario-driven guide explains how Deferiprone (SKU B1723) can improve experimental control in viability, proliferation, and cytotoxicity assays. It connects iron-chelation chemistry with practical dosing, compatibility, interpretation, and vendor-selection decisions for biomedical laboratories.
-
Reactive Oxygen Species Assay Kit: DHE Workflow
2026-09-21
Build a superoxide-focused oxidative stress assay for living cells with practical guidance on DHE loading, controls, normalization, and imaging or plate-based readouts. The workflow translates recent osteoarthritis research into assay decisions that support redox signaling, senescence, and apoptosis research.
-
HITT, ATM Activation, and Cancer Sensitization
2026-09-21
The reference study identifies HITT as a DNA damage–induced long noncoding RNA that directly restrains ATM recruitment and activation, thereby weakening homologous recombination repair. Its findings establish a mechanistic basis for using ATM-pathway disruption to increase cancer-cell sensitivity to genotoxic treatment while also clarifying important limits for translation into disease-specific models.